NASDAQ: ELVN - Enliven Therapeutics, Inc.
Доходность за полгода: +40.98%
Сектор: Healthcare
| Параметр | Оценка | Значение | Среднее по сектору | Разница с сектором, % | Средняя за 5 лет | Разница со средней, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-11.28 | 47.96 | -123.53% | 203.79 | -105.54% |
P/E Forward 
|
|
-10.88 | 203.79 | -105.34% | ||
| P/S |
|
0 | 33.73 | -100% | 0 | 0% |
| P/S Forward |
|
0 | 0 | 0% | ||
| P/BV |
|
10.38 | 4.81 | 116.01% | -46.43 | -122.37% |
| P/BV Forward |
|
22.66 | -46.43 | -148.8% | ||
| Ev/Ebitda |
|
-4.99 | -22.5 | -77.82% | -78.31 | -93.63% |
| Ev/Ebitda Forward |
|
-4.55 | -78.31 | -94.18% |
